Plant Advanced Technologies SA (ALPAT) - Total Assets
Based on the latest financial reports, Plant Advanced Technologies SA (ALPAT) holds total assets worth €16.37 Million EUR (≈ $19.13 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Plant Advanced Technologies SA - Total Assets Trend (2008–2025)
This chart illustrates how Plant Advanced Technologies SA's total assets have evolved over time, based on quarterly financial data. Also see market cap of Plant Advanced Technologies SA for the company's overall valuation and market capitalisation.
Plant Advanced Technologies SA - Asset Composition Analysis
Current Asset Composition (December 2025)
Plant Advanced Technologies SA's total assets of €16.37 Million consist of 18.6% current assets and 81.4% non-current assets. Review Plant Advanced Technologies SA total liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0.3% |
| Accounts Receivable | €1.71 Million | 10.5% |
| Inventory | €1.21 Million | 7.4% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €3.70 Million | 22.6% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2008–2025)
This chart illustrates how Plant Advanced Technologies SA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See latest Plant Advanced Technologies SA stock price today for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Plant Advanced Technologies SA's current assets represent 18.6% of total assets in 2025, a decrease from 38.8% in 2008.
- Cash Position: Cash and equivalents constituted 0.3% of total assets in 2025, down from 12.4% in 2008.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 22.0% of total assets, a decrease from 23.0% in 2008.
- Asset Diversification: The largest asset category is intangible assets at 22.6% of total assets.
Plant Advanced Technologies SA Competitors by Total Assets
Key competitors of Plant Advanced Technologies SA based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Abivax SA
PA:ABVX
|
France | €547.14 Million |
|
Shanghai RAAS Blood Products Co Ltd Class A
SHE:002252
|
China | CN¥37.46 Billion |
|
Braveheart Bio, Inc. Common Stock
NASDAQ:BRVE
|
USA | $126.96 Million |
|
Neuren Pharmaceuticals Ltd
AU:NEU
|
Australia | AU$331.25 Million |
|
Lifecome Biochemistry Co Ltd
SHE:002868
|
China | CN¥729.16 Million |
|
Pulike Biological Engineering
SHG:603566
|
China | CN¥3.09 Billion |
|
Rocket Pharmaceuticals Inc
NASDAQ:RCKT
|
USA | $423.10 Million |
|
NEWRON PHARMACEUT. EO-20
XETRA:NP5
|
Germany | €40.03 Million |
Plant Advanced Technologies SA - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.59 | 0.99 | 1.84 |
| Quick Ratio | 0.36 | 0.52 | 1.44 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €-2.09 Million | €-16.52K | €2.33 Million |
Plant Advanced Technologies SA - Advanced Valuation Insights
This section examines the relationship between Plant Advanced Technologies SA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.50 |
| Latest Market Cap to Assets Ratio | 0.30 |
| Asset Growth Rate (YoY) | 2.3% |
| Total Assets | €16.37 Million |
| Market Capitalization | $4.92 Million USD |
Valuation Analysis
Below Book Valuation: The market values Plant Advanced Technologies SA's assets below their book value (0.30x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Plant Advanced Technologies SA's assets grew by 2.3% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Plant Advanced Technologies SA (2008–2025)
The table below shows the annual total assets of Plant Advanced Technologies SA from 2008 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | €16.37 Million ≈ $19.13 Million |
+2.30% |
| 2024-12-31 | €16.00 Million ≈ $18.70 Million |
+7.27% |
| 2023-12-31 | €14.91 Million ≈ $17.43 Million |
-12.69% |
| 2022-12-31 | €17.08 Million ≈ $19.97 Million |
-0.16% |
| 2021-12-31 | €17.11 Million ≈ $20.00 Million |
-0.92% |
| 2020-12-31 | €17.27 Million ≈ $20.19 Million |
+24.33% |
| 2019-12-31 | €13.89 Million ≈ $16.24 Million |
+109139.65% |
| 2018-12-31 | €12.71K ≈ $14.86K |
+29.73% |
| 2017-12-31 | €9.80K ≈ $11.46K |
+0.03% |
| 2016-12-31 | €9.80K ≈ $11.45K |
-6.17% |
| 2015-12-31 | €10.44K ≈ $12.21K |
+89.55% |
| 2014-12-31 | €5.51K ≈ $6.44K |
-99.87% |
| 2013-12-31 | €4.26 Million ≈ $4.98 Million |
+20.23% |
| 2012-12-31 | €3.54 Million ≈ $4.14 Million |
+22.86% |
| 2011-12-31 | €2.88 Million ≈ $3.37 Million |
-10.44% |
| 2010-12-31 | €3.22 Million ≈ $3.76 Million |
+214.83% |
| 2009-12-31 | €1.02 Million ≈ $1.19 Million |
+92.83% |
| 2008-12-31 | €529.89K ≈ $619.49K |
-- |
About Plant Advanced Technologies SA
Plant Advanced Technologies SA, a plant biotechnology company, produces and sells actives for cosmetic, pharmaceutical, and agrochemical markets in France. Its technologies include Process PAT Exudactive a sustainable sourcing solution to produce your exclusive, personalized Exudactive; and PAT Target Binding, which finds the ligands that bind to the protein targets of interest, such as enzymes. … Read more